Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTICE OF ANNUAL GENERAL MEETING

The shareholders of Ziccum AB (publ) are hereby invited to attend the Annual General Meeting on May 20, 2019 at 14.00 at Hälsovägen 7 in Flemingsberg. Voting rights registration starts at. 13.30, and is cancelled when the meeting opens. NOTE: This is an unofficial translation of the original notice, which is in Swedish. In case of discrepancies, the Swedish version shall prevail.Right to participate The right to participate in the Annual General Meeting has been the one that has been recorded as a shareholder in the share register kept by Euroclear Sweden AB regarding the

Akastor ASA: Invitation to presentation of first quarter results 2019

Akastor ASA will publish its first quarter 2019 results on Thursday May 2, 2019 at 7:00 a.m. CET. The report and presentation will be available through a conference call and audiocast only, at 8:00 a.m. CET. The presentation will be audiocasted live, and available through a dial-in conference call. There will be a Q&A session following the presentation. The replay will be made available on the company website. To join this event, please use the below link 5-10 minutes prior to start time for the easiest way to join your conference. You will be asked to enter your phone number and

Zutec enter into a Co-Marketing agreement with Danalto

Zutec are delighted to announce that we have entered into a co-marketing agreement with Danalto Limited, one of the leading players in the IoT space. Through this partnership Zutec and Danalto will provide end to end IoT solutions across a range of applications including the mining industry, construction and Smartcities. As part of this agreement both Zutec and Danalto will cooperate to leverage complimentary skills and technologies in the rapidly expanding IoT space. Initally both companies agree to sell and promote each other's products and services to their respective customer bases

Magnolia Bostad invites you to a conference call on 25 April with the publication of Q1 2019

Magnolia Bostad is publishing its first-quarter report for 2019, on 25 April at around 07:30 a.m. CEST and invites you to a conference call at. 10.30 a.m. CEST on the same day.TeleconferenceInvestors, analysts, shareholders and the media are invited to a conference call: Date: 25 April 2019Time: 10.30 a.m. CEST Fredrik Lidjan, CEO and Fredrik Westin, CFO, will comment on the results, after this there will be time for questions. The conference call will be held in Swedish. The conference call will be held in Swedish. To take part in the conference call and ask questions, please

Beijer Ref AB Q1-2019

Continued strong developmentNet Sales increased by 32 per cent in the first quarter compared to the same period last year and amounted to SEK 3,434 million (2,605). Organic growth was 8%. The operating profit for the quarter amounted to SEK 244 million (172), an increase of 42% compared with the same period last year. The operating margin was 7.1% (6.6%), of which 0.2% is a positive IFRS 16 effect. Profit for the period totalled SEK 170 million (121). Profit per share totalled SEK 1.33 (0.92). With effect from 1 January 2019, the company applies IFRS 16 with regard to the group's

Altia Plc: Notice of the Annual General Meeting

Altia Plc Stock Exchange Release 16 April 2019 at 9:30 am EET Altia Plc: Notice of the Annual General Meeting Notice is given to the shareholders of Altia Plc of the Annual General Meeting to be held on Wednesday, 15 May 2019 at 4.00 p.m. at Kaapelitehdas, Tammasaarenlaituri 5, entrance M1, 00180 Helsinki, Finland. The reception of attendees who have registered for the meeting will commence at 2.30 p.m. A. Matters on the agenda of the Annual General Meeting The following matters will be considered at the Annual General Meeting: 1. Opening of the meeting 2. Calling the

ChromoGenics publishes the annual report 2018

ChromoGenics publishes the annual report 2018ChromoGenics annual report for 2018, in Swedish, is now available on  https://www.chromogenics.com/investor-relations/ in pdf-format. The annual report can also be ordered in print from the company and distributed via post to shareholders on demand. The Annual General Meeting will take place Wednesday May 15, 2019 at 14.00 CET in Advokatfirman Lindahl’s offices on Vaksalagatan 10, Uppsala. Complete notifications and documents will be available at https://www.chromogenics.com/investor-relations/

Notice of Paradox Interactive AB (publ)’s Annual General Meeting 2019

Shareholders in Paradox Interactive AB (publ), 556667-4759 are hereby invited to the Annual General Meeting (AGM) to be held May 17, 2019 13.00 CET at Biograf Victoria, Götgatan 67, 116 21 Stockholm.Please note that this translation is for information purposes only – in case of any discrepancies between this version and the Swedish version of the Notice, the Swedish version shall prevail. The Annual General Meeting will be held in Swedish only. Notice of attendance  Shareholders who wish to attend the AGM shall: · be entered in the company’s shareholders’ register kept by

LightLab Sweden introduces new UV chip products for sustainable and efficient disinfection of food, surfaces, air and drinking water

LightLab Sweden today announced the availability of its new UV chip products for sustainable and efficient disinfection of food, surfaces, air and drinking water. Based on LightLab Sweden’s EEE Light® technology – a field emission UV-C technology using unique nanotechnology – the UV chips offers significant advantages with high performance and attractive cost, making them uniquely suited for consumer near applications. The UV chips from LightLab Sweden are designed for easy integration into products featuring disinfection functionality and have a proven high germicidal effectiveness,

Mycronic launches a cost-efficient mask writer for the mature photomask market

Mycronic AB (publ) launches the new mask writer, Prexision Lite 8, for the low to mid-end display photomask market. Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas. The Prexision Lite 8 mask writer is built on a new platform and designed to meet the requirements for cost-efficient production of photomasks for main stream displays

Enzymatica’s cold spray launched in South Africa

Enzymatica’s partner ABEX Pharmaceutica (Pty) Ltd has now launched the cold spray ColdGuard™ (ColdZyme®) in the South African market. ABEX is conducting an extensive marketing campaign, including advertising in traditional media and in-store advertising, as well as commercials and marketing in various digital media channels, to ensure effective market awareness to the South African consumers. South Africa is the first market to even out the current seasonal variation in sales of ColdZyme, as the cold season in the southern hemisphere lasts from April to September.After having signed a

Basware publishes Interim Report for January-March 2019 on Tuesday, April 30, 2019 at 08.45 am EET

Basware Corporation, press release, April 16, 2019 at 9.30 am EESTBasware Corporation publishes its Interim report for the period January 1 – March 31, 2019 on Tuesday, April 30, 2019 at 08.45 am EET. The report and presentation material will be available on the company’s investor website at investors.basware.com/en after publishing.Basware arranges a briefing for analysts and press, where interim CEO Klaus Andersen and CFO Niclas Rosenlew will comment on the events and financial performance of the past quarter. The results briefing can be followed via live webcast or teleconference. A

Rejlers helps the City of Stockholm with data management for solar electricity production

The City of Stockholm has tasked Rejlers Embriq with collecting and managing data from solar electricity production at all of the City’s photovoltaic plants in order to allow the City to follow up on its goals for renewable electricity production and to fulfil the authorities’ demands for collection and reporting of electricity certificates.The use of solar energy (direct conversion of solar radiation into heat and electricity) plays a significant role in sustainable energy supply in Sweden, and Swedish companies are among the leaders in Europe. “The City of Stockholm is looking forward

C-RAD meddelar att teckningsoptioner har utnyttjats och att tilldelning av aktier skett

C-RAD AB (publ) ("C-RAD" eller "Bolaget") meddelar att 264 000 teckningsoptioner som emitterades efter beslut av årsstämman den 14 april 2016 har utnyttjats av innehavare till en kurs om 11,80 kronor och att styrelsen för Bolaget därmed beslutat att tilldela 264 000 aktier av serie B till tecknarna. Styrelsen för C-RAD har beslutat att tilldela 264 000 aktier av serie B som tecknats i enlighet med villkoren för teckningsoptionerna som emitterades efter beslut av årsstämman den 14 april 2016. Varje teckningsoption berättigar till teckning av en ny aktie av serie B i Bolaget till en

Results from the EDCR IIa trial where Diamyd® is given subcutaneously

30-month results from EDCR IIa, an investigator initiated pilot trial in which the diabetes vaccine Diamyd® is given subcutaneously combined with etanercept and vitamin D, show that the treatment is safe and tolerable. No serious side effects have been reported. As expected, based on previously reported 15-month results, the results at 30 months show no clear positive effect on the clinical course of the disease.When all 20 patients had been followed for 30 months in the EDCR IIa trial, endogeonus insulin production (measured as stimulated C-peptide) had decreased on average by 70% and

Notice of the Annual General Meeting in Nexam Chemical Holding AB (publ)

The shareholders of Nexam Chemical Holding AB (publ), corporate identity 556919-9432, are hereby convened to the Annual General Meeting (“AGM”), to be held at 3.00 p.m. on Thursday, May 16 2019 at Elite Hotel Ideon, Scheelevägen 27, in Lund. Admission for registration from 2.00 p.m.Notice of the Annual General Meeting 2019 The shareholders of Nexam Chemical Holding AB (publ), (“Nexam Chemical”), are hereby convened to attend the Annual General Meeting (“AGM”) held at 3.00 p.m. on Thursday, May 16 2019 at Elite Hotel Ideon, Scheelevägen 27, in Lund. Entitlement to participate and

Interim Report January-March 2019

First quarter 2019 compared to first quarter 2018 · Customer growth was good and 33,600 (42,400) new customers were added · Net inflow in the quarter was SEK 7,570 million (7,960), a decrease of 5 per cent · Operating income decreased by 1 per cent due to lower brokerage income and other income. The brokerage income decreased due to lower brokerage per commission note. Net interest income was improved. · Operating expenses increased by 8 per cent, mainly due to higher personnel cost. The long-term guidance on Avanza’s annual cost increase is 9-12 per cent, the current budget

Telefonica Peru chooses Tecnotree to deliver a new Service Delivery Platform

Tecnotree OyjPress ReleaseApril 16, 2019 at 9:10 am (EEST)Finland – 16 April: Tecnotree , the global provider of BSS solutions for the telecom industry, announced today that it has signed a contract with Telefonica Peru, to replace their current middleware and service delivery platform. With this contract, Tecnotree continues expanding market share in Latin America, and shows further commitment to grow the business with a very strong portfolio of products suiting the customer needs.  Tecnotree solution will allow Telefonica Peru to move to a completely new

Notice of annual shareholders’ meeting in Polygiene AB (publ)

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders of Polygiene AB (publ), Reg. No. 556692-4287, are hereby invited to attend the annual shareholders’ meeting to be held on Friday 17 May 2019, at 12.00 p.m., at Malmö Börshus, Skeppsbron 2, in Malmö.Right to participate and notification Shareholders wishing to participate in the meeting must · partly be listed in the company’s share register kept by Euroclear Sweden AB as of Saturday 11 May 2019; and ·

Procurement technology innovator Cloudia nominated in World Procurement Awards

Nomination in Procurement Technology category recognition for customer-centric product developmentProcurement solutions provider Cloudia  has been named as a finalist in the World Procurement Awards  in the Procurement Technology category. Cloudia’s customer-centric, fully-digital approach helped them develop procurement technologies that drive down costs and save time through process automation and digital resource management. “We’re extremely happy that our approach to product

Nixu Corporation’s revenue information and CEO’s review for Q1 2019

Nixu CorporationPress release on April 16, 2019 at 9.05 AM EESTIn accordance with its disclosure policy, the cybersecurity company Nixu releases its half-year review and financial statement, including revenue figures for the first and third quarters of the year. After Nixu's last year's transfer to the Nasdaq Helsinki main list, we now include a free-format CEO’s review to our quarterly reports. Nixu announced today that its unaudited revenue for January – March 2019 was EUR 12.6 million, whereas the revenue in the comparison period of January – March 2018 was EUR 9.2 million. Growth

Scandion Oncology signs collaboration agreement with University of Copenhagen regarding co-development of a class of drug candidates that reverts anti-cancer drug resistance

Scandion Oncology A/S (”Scandion” or ”the Company”) announces today that the Company has signed a collaboration agreement with Department of Drug Design and Pharmacology, University of Copenhagen regarding development of a class of drugs that can revert anti-cancer drug resistance. The lead compound from this drug class, named SCO-301, complements Scandion’s drug portfolio, since it targets resistance against a large class of anti-cancer drugs that is not targeted by SCO-101 or SCO-201. Scandion has thus already fulfilled one of the milestones for 2020.By using the DEN50-R drug screening

Invitation to presentation of AcadeMedia's quarterly report for July - March 2018/19

AcadeMedia's quarterly report for July - March 2018/19 will be published at 08:00 CET on May 7. A web-cast telephone conference will be held at 09:30 CET the same day, where CEO Marcus Strömberg and CFO Eola Änggård Runsten will present the report. The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call: SE: +46 8 566 427 04UK: +44 33 3300 9266US: +1 833

There are no items matching the current filter
There are no more items matching the current filter
Back to top